AVEO

Welcome to the Brand page for “AVEO”, which is offered here for In the statement, column 1, lines 5 through column 2, line 2, pharmaceuticals and medical diagnostic reagents for the treatment and diagnosis of cancer, autoimmune diseases, inflammatory diseases, allergic diseases, neurodegenerative diseases, brain damage, psychiatric disorders, pain, cardiovascular diseases, metabolic diseases, gastrointestinal disorders, endocrinological disorder, viral infections, bacterial infections and fungal infections is deleted, and, pharmaceuticals for the treatment of cancer is inserted.;pharmaceuticals [ and medical diagnostic reagents ] for the treatment [ and diagnosis ] of cancer [, autoimmune diseases, inflammatory diseases, allergic diseases, neurodegenerative diseases, brain damage, psychiatric disorders, pain, cardiovascular diseases, metabolic diseases, gastrointestinal disorders, endocrinological disorder, viral infections, bacterial infections and fungal infections ];.

Its status is currently believed to be active. Its class is unavailable. “AVEO” is believed to be currently owned by “AVEO PHARMACEUTICALS, INC.”